Sultan Almuntashiri
Overview
Explore the profile of Sultan Almuntashiri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dutta S, Zhu Y, Han Y, Almuntashiri S, Wang X, Zhang D
J Clin Med
. 2023 Jan;
12(2.
PMID: 36675533
Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), represent an acute stage of lung inflammation where the alveolar epithelium loses its functionality. ALI has a...
12.
Extracellular vesicle-encapsulated CC16 as novel nanotherapeutics for treatment of acute lung injury
Han Y, Zhu Y, Almuntashiri S, Wang X, Somanath P, Owen C, et al.
Mol Ther
. 2023 Jan;
31(5):1346-1364.
PMID: 36635966
Acute lung injury (ALI) is still associated with high mortality. Growing evidence suggests that Club Cell Protein 16 (CC16) plays a protective role against ALI. However, the doses of recombinant...
13.
Almuntashiri S, Jones T, Wang X, Sikora A, Zhang D
Biol Sex Differ
. 2022 Dec;
13(1):70.
PMID: 36482481
Background: Acute respiratory distress syndrome (ARDS) confers high morbidity and mortality, with a death rate reaching 40%. Pre-clinical and clinical studies have cited sex-specific sex hormones as a critical contributor...
14.
Almuntashiri S, Han Y, Youngblood H, Chase A, Zhu Y, Wang X, et al.
Physiol Rep
. 2022 Nov;
10(21):e15494.
PMID: 36353917
Acute respiratory distress syndrome (ARDS) is a lethal disease with severe forms conferring a mortality rate approaching 40%. The initial phase of ARDS results in acute lung injury (ALI) characterized...
15.
Han Y, Zhu Y, Youngblood H, Almuntashiri S, Jones T, Wang X, et al.
J Control Release
. 2022 Nov;
352:556-569.
PMID: 36341934
Small extracellular vesicles (sEVs) are a group of cell-secreted nanovesicles with a diameter up to 200 nm. A growing number of studies have indicated that sEVs can reflect the pathogenesis...
16.
Almuntashiri S, Chase A, Sikora A, Zhang D
Ann Pharmacother
. 2022 Oct;
57(7):757-761.
PMID: 36189647
Background: Critically ill patients are often prescribed both inhaled beta-agonists and intravenous vasoactive; however, the interaction of the additive beta-agonist effects of these 2 agents remains largely uncharacterized. Objective: The...
17.
Zhu Y, Han Y, Almuntashiri S, Dutta S, Wang X, Owen C, et al.
Am J Respir Cell Mol Biol
. 2022 Sep;
67(6):695-707.
PMID: 36066909
Cigarette smoke (CS) is considered a major risk factor for chronic obstructive pulmonary disease (COPD) that is currently the third leading cause of death in the United States. Studies have...
18.
Almuntashiri S, Zhang D, Somanath P, Sikora A
Infect Disord Drug Targets
. 2022 Jun;
23(1):e190622206159.
PMID: 35726419
Identifying novel therapies is a critical need in the treatment of coronavirus disease-19 (COVID-19) and acute respiratory distress syndrome (ARDS). Stromelysin-1, also known as matrixmetalloproteinase 3 (MMP3), has been investigated...
19.
Chase A, Almuntashiri S, Sikora A, Zhang D
Crit Care Explor
. 2022 Jun;
4(6):e0711.
PMID: 35651737
Design: A secondary biomarker analysis of a prospective randomized-controlled trial. The primary outcome was area under the receiver operating characteristic (AUROC) of CC16 for prediction of 90-day mortality. Secondary outcomes...
20.
Almuntashiri S, Han Y, Zhu Y, Dutta S, Niazi S, Wang X, et al.
Int J Mol Sci
. 2021 Nov;
22(21).
PMID: 34768890
Gram-negative (G-) bacteria are the leading cause of hospital-acquired pneumonia in the United States. The devastating damage caused by G- bacteria results from the imbalance of bactericidal effects and overwhelming...